We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current ENGN market cap is 560.46M. The company's latest EPS is CAD -2.2927 and P/E is -5.43.
| Quarter End | Jul 2023 |
|---|---|
| CAD ($) | |
| Total Revenue | 0 |
| Operating Income | -72.1M |
| Net Income | -72.49M |
| Year End 31 October 2023 | 2023 |
|---|---|
| CAD ($) | |
| Total Revenue | 0 |
| Operating Income | -26.06M |
| Net Income | -99.92M |
| Quarter End | Jul 2023 |
|---|---|
| CAD ($) | |
| Total Assets | 7k |
| Total Liabilities | 72.49M |
| Total Equity | -72.48M |
| Year End 31 October 2023 | 2023 |
|---|---|
| CAD ($) | |
| Total Assets | 86.96M |
| Total Liabilities | 14.47M |
| Total Equity | 72.49M |
| Market Cap | 560.46M |
| Price to Earnings Ratio | -5.43 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 6.66 |
| Price to Book Ratio | 7.49 |
| Dividend Yield | - |
| Shares Outstanding | 43.58M |
| Average Volume (1 week) | 5.63k |
| Average Volume (1 Month) | 90.78k |
| 52 Week Change | -24.31% |
| 52 Week High | 43.00 |
| 52 Week Low | 6.69 |
| Spread (Intraday) | 9.7 (46.86%) |
| Company Name | enGene Holdings Inc |
| Address |
suite 2600, three bentall centre, 595 burrard street vancouver, british columbia V7X 1L3 |
| Website | https:// |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
